On ECHEMI
Home > Drugs > Light chain disease and light chain deposition disease
Light chain disease and light chain deposition disease
Light chain disease (LCD) and light chain deposition disease (LCDD) are plasma cell abnormal proliferation diseases. Light chain disease is caused by abnormal plasma cells producing too many light chains, while the synthesis of heavy chains is correspondingly reduced. The excessive free light chain fragments appearing in serum or urine are called light chain disease; once immunoglobulin light chains are deposited in tissues throughout the body, causing corresponding clinical manifestations, it is called light chain deposition disease.
  • Site of disease:

    Bone blood vessels whole body
  • Infectious :

    Not contagious
  • Frequent population:

    This disease is more common in middle-aged and elderly people (>45 years old)
  • Related symptoms:

    Bleeding tendency bone destruction bone pain weakness lymph node enlargement
  • Concurrent disease:

Related Drugs
Ubenimex Capsules
Indication: This product can enhance immune function and is used for adjuvant therapy of anti-cancer chemotherapy and radiotherapy, elderly immune deficiency, etc. It can be used in conjunction with chemotherapy, radiotherapy and in combination with leukemia, multiple myeloma, myelodysplastic syndrome, hematopoietic stem cell transplantation, and other solid tumor patients.
Manufacturer:

Sichuan Luye Pharmaceutical Industry Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.